117 related articles for article (PubMed ID: 15279671)
1. Overexpression of p16INK4A and p14ARF in haematological malignancies.
Güran S; Beyan C
Clin Lab Haematol; 2004 Aug; 26(4):303. PubMed ID: 15279671
[No Abstract] [Full Text] [Related]
2. Overexpression of p16INK4A and p14ARF in haematological malignancies.
Lee YK; Park JY; Kang HJ; Cho HC
Clin Lab Haematol; 2003 Aug; 25(4):233-7. PubMed ID: 12890162
[TBL] [Abstract][Full Text] [Related]
3. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
[TBL] [Abstract][Full Text] [Related]
5. The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma.
Sarasquete ME; García-Sanz R; Armellini A; Fuertes M; Martín-Jiménez P; Sierra M; Del Carmen Chillón M; Alcoceba M; Balanzategui A; Ortega F; Hernández JM; Sureda A; Palomera L; González M; San Miguel JF
Haematologica; 2006 Nov; 91(11):1551-4. PubMed ID: 17043023
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppression for ARFicionados: the relative contributions of p16INK4a and p14ARF in melanoma.
Peters G
J Natl Cancer Inst; 2008 Jun; 100(11):757-9. PubMed ID: 18505965
[No Abstract] [Full Text] [Related]
7. Expression of the cell cycle regulators p14(ARF) and p16(INK4a) in chronic myeloid leukemia.
Cividin M; Ayrault O; Sorel N; Séité P; Brizard F; Blanchet O; Mahon FX; Guilhot F; Larsen C; Chomel JC; Brizard A
Leuk Res; 2006 Oct; 30(10):1273-8. PubMed ID: 16533530
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
Lee M; Sup Han W; Kyoung Kim O; Hee Sung S; Sun Cho M; Lee SN; Koo H
Pathol Res Pract; 2006; 202(6):415-24. PubMed ID: 16675157
[TBL] [Abstract][Full Text] [Related]
9. Re: Oda et al. Frequent alteration of p16INK4a/p14ARF and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14ARF expression both correlate with poor prognosis. J Pathol 2005;207:410-421.
Perrone F; Tamborini E; Suardi S; Lagonigro MS; Pilotti S
J Pathol; 2006 Jun; 209(2):281; author reply 282. PubMed ID: 16622896
[No Abstract] [Full Text] [Related]
10. A comparison analysis of anti-tumor efficacy of adenoviral gene replacement therapy (p14ARF and p16INK4A) in human mesothelioma cells.
Yang CT; You L; Lin YC; Lin CL; Mccormick F; Jablons DM
Anticancer Res; 2003; 23(1A):33-8. PubMed ID: 12680192
[TBL] [Abstract][Full Text] [Related]
11. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
Nagy E; Veress G; Szarka K; Csoma E; Beck Z
Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma.
Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Iwamoto Y; Tsuneyoshi M
Cancer Sci; 2004 Aug; 95(8):651-5. PubMed ID: 15298727
[TBL] [Abstract][Full Text] [Related]
14. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
[TBL] [Abstract][Full Text] [Related]
15. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
[TBL] [Abstract][Full Text] [Related]
17. Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas.
Simão Tde A; Simões GL; Ribeiro FS; Cidade DA; Andreollo NA; Lopes LR; Macedo JM; Acatauassu R; Teixeira AM; Felzenszwalb I; Pinto LF; Albano RM
Hum Exp Toxicol; 2006 Sep; 25(9):515-22. PubMed ID: 17017004
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice.
Sung YH; Park J; Choi B; Kim J; Cheong C; Choi YS; Yang EY; Lee M; Han JS; Park SC; Han TH; Kim TJ; Song J; Rhee K; Lee HW
Mech Ageing Dev; 2005; 126(6-7):732-9. PubMed ID: 15888328
[TBL] [Abstract][Full Text] [Related]
19. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C
Endocr Relat Cancer; 2008 Jun; 15(2):609-21. PubMed ID: 18509008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
